Outpatient Care Compared with Hospitalization for Community-Acquired Pneumonia
Top Cited Papers
- 1 February 2005
- journal article
- clinical trial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 142 (3) , 165-172
- https://doi.org/10.7326/0003-4819-142-3-200502010-00006
Abstract
The Pneumonia Severity Index (PSI) has been advocated as an objective measure of risk stratification to help determine the initial site of treatment for patients with community-acquired pneumonia. To determine whether outpatient care of PSI-defined low-risk patients with community-acquired pneumonia is as safe and effective as hospitalization. Unblinded, randomized, controlled trial. 2 tertiary care hospitals. 224 immunocompetent adults in risk class II or III (PSI scores <or=90 points) who received a diagnosis of community-acquired pneumonia in the emergency department and had no extenuating circumstances. Outpatient care with oral levofloxacin therapy or hospitalization with sequential intravenous and oral levofloxacin therapy. The primary end point was the percentage of patients with an overall successful outcome at the end of treatment, according to 7 predefined criteria. Secondary end points included patients' quality of life and satisfaction. Overall successful outcome was achieved in 83.6% of outpatients and 80.7% of hospitalized patients (absolute difference, 2.9 percentage points [95% CI, -7.1 to 12.9 percentage points]). More outpatients were satisfied with their overall care (91.2% vs. 79.1%; absolute difference, 12.1 percentage points [CI, 1.8 to 22.5 percentage points]). Quality of life and the percentages of patients with adverse drug reactions (9.1% vs. 9.6%), medical complications (0.9% vs. 2.6%), subsequent hospital admissions (6.3% vs. 7.0%), and overall mortality (0.9% vs. 0%) were similar in the outpatient and hospitalization groups. The power to detect a serious complication, such as death, was limited given the relatively small sample size. In selected patients who had community-acquired pneumonia, PSI risk class II and III, and were treated with levofloxacin, outpatient care in the absence of respiratory failure, unstable comorbid conditions, complicated pleural effusions, and social problems was as safe and effective as hospitalization and provided greater patient satisfaction.Keywords
This publication has 21 references indexed in Scilit:
- Causes and Factors Associated With Early Failure in Hospitalized Patients With Community-Acquired PneumoniaArchives of internal medicine (1960), 2004
- A Controlled Trial of a Critical Pathway for Treatment of Community-Acquired PneumoniaJAMA, 2000
- New directions for future studies of community-acquired pneumonia: optimizing impact on patient care.European Journal of Clinical Microbiology & Infectious Diseases, 1999
- USE OF PROGNOSTIC SCORING AND OUTCOME ASSESSMENT TOOLS IN THE ADMISSION DECISION FOR COMMUNITY-ACQUIRED PNEUMONIAClinics in Chest Medicine, 1999
- The cost of treating community-acquired pneumoniaClinical Therapeutics, 1998
- Safely Increasing the Proportion of Patients With Community-Acquired Pneumonia Treated as OutpatientsArchives of internal medicine (1960), 1998
- Time to Clinical Stability in Patients Hospitalized With Community-Acquired PneumoniaJAMA, 1998
- Measuring symptomatic and functional recovery in patients with community-acquired pneumoniaJournal of General Internal Medicine, 1997
- Preferences for Home vs Hospital Care Among Low-Risk Patients With Community-Acquired PneumoniaArchives of internal medicine (1960), 1996
- Prognosis and Outcomes of Patients With Community-Acquired PneumoniaJAMA, 1996